A Structured Benefit-Risk Assessment Operating Model for Investigational Medicinal Products in the Pharmaceutical Industry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
A Structured Benefit-Risk Assessment Operating Model for Investigational Medicinal Products in the Pharmaceutical Industry ; volume:57 ; number:4 ; day:1 ; month:4 ; year:2023 ; pages:849-864 ; date:7.2023
Therapeutic innovation & regulatory science ; 57, Heft 4 (1.4.2023), 849-864, 7.2023
- Urheber
-
Sullivan, Tim
Zorenyi, Gyorgy
Feron, Jane
Smith, Meredith
Nord, Magnus
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s43441-023-00508-2
- URN
-
urn:nbn:de:101:1-2023092208075455268599
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sullivan, Tim
- Zorenyi, Gyorgy
- Feron, Jane
- Smith, Meredith
- Nord, Magnus
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Book of Recipes for Pharmaceutical and Medicinal Preparations ... : ABC
Can computer vision problems benefit from structured hierarchical classification?
Basic tests for drugs : pharmaceutical substances, medicinal plant materials and dosage forms
Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
EC guide to good manufacturing practice for medicinal products and active pharmaceutical ingredients
Innovations in Pharmaceutical Industry : How to Work Towards a Global Benefit for Consumers
Investment certificates under German taxation: Benefit or burden for structured products' performance?
Implementation of a structured emergency nursing framework results in significant cost benefit
High-resolution anoscopy, is there a benefit in proceeding directly to the operating room?
European Coalition on Homoeopathic and Anthroposophic Medicinal Products / Infobroschüre / Review of the Pharmaceutical Legislation.
Medicinal Chemistry Graduate School Curriculum and Its Contribution to the Pharmaceutical Industry in Japan
The Book of Recipes for Pharmaceutical and Medicinal Preparations ... : ABC
Can computer vision problems benefit from structured hierarchical classification?
Basic tests for drugs : pharmaceutical substances, medicinal plant materials and dosage forms
Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
EC guide to good manufacturing practice for medicinal products and active pharmaceutical ingredients
Innovations in Pharmaceutical Industry : How to Work Towards a Global Benefit for Consumers
Investment certificates under German taxation: Benefit or burden for structured products' performance?
Implementation of a structured emergency nursing framework results in significant cost benefit
High-resolution anoscopy, is there a benefit in proceeding directly to the operating room?
European Coalition on Homoeopathic and Anthroposophic Medicinal Products / Infobroschüre / Review of the Pharmaceutical Legislation.
Medicinal Chemistry Graduate School Curriculum and Its Contribution to the Pharmaceutical Industry in Japan
The Book of Recipes for Pharmaceutical and Medicinal Preparations ... : ABC
Can computer vision problems benefit from structured hierarchical classification?
Basic tests for drugs : pharmaceutical substances, medicinal plant materials and dosage forms
Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
EC guide to good manufacturing practice for medicinal products and active pharmaceutical ingredients
Innovations in Pharmaceutical Industry : How to Work Towards a Global Benefit for Consumers
Investment certificates under German taxation: Benefit or burden for structured products' performance?
Implementation of a structured emergency nursing framework results in significant cost benefit
High-resolution anoscopy, is there a benefit in proceeding directly to the operating room?
European Coalition on Homoeopathic and Anthroposophic Medicinal Products / Infobroschüre / Review of the Pharmaceutical Legislation.